At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Cryoablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System
In Brief
A clinical study evaluating Cryoablation for Atrial Fibrillation. Completed, enrolled 10 participants across 2 sites.
Detailed Summary
Primary Endpoint Safety and tolerability of ablation using the AFreeze Cryoablation System consisting of the ablation CoolLoop® catheter, its steerable sheath and the cryoconsole Cryo-Caddy will be assessed and expressed in number of participants with Adverse Events (AEs).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesAustria
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2012
First PostedSep 2012
Primary CompletionMar 2013
Study CompletionJun 2013
TodayJul 2026
First PostedSep 18, 2012
Enrollment StartSep 1, 2012
Primary CompletionMar 1, 2013
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 13.8 years ago
Interventions
Cryoablationdevice
Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System